Income Statement - Edgewise Therapeutics, Inc. (EWTX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of revenue | 2.27 | 2.29 | 1.73 | 0.54 | 0.27 | 0.19 | 0.12 |
| Gross profit | -2.27 | -2.29 | -1.73 | -0.54 | -0.27 | -0.19 | -0.12 |
| Total operating expenses | 189.14 | 158.83 | 114.36 | 22.08 | 43.22 | 17.01 | 9.92 |
| Operating income | -191.41 | -158.83 | -114.36 | -22.08 | -43.22 | -17.19 | -9.92 |
| Non-operating income (net) | 23.61 | 25.02 | 14.19 | 2.66 | 0.40 | 0.07 | 0.22 |
| Income before tax | -167.80 | -133.81 | -100.16 | -19.42 | -42.81 | -17.12 | -9.71 |
| Income tax expense | 0.00 | -4.02 | -0.67 | -0.07 | -0.22 | ||
| Net income | -167.80 | -133.81 | -100.16 | -15.40 | -42.14 | -17.05 | -9.49 |
Show Quarterly Income Statement
Income Statement - Edgewise Therapeutics, Inc. (EWTX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.12 | 0.00 | 0.00 | 0.00 | 2.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of revenue | 0.59 | 0.57 | 0.55 | 1.06 | 2.29 | 0.53 | 0.53 | 0.53 | 0.45 | 0.44 | 0.24 | 0.09 | 0.17 | 0.15 | 0.13 | 0.08 | 0.06 | 0.05 | 0.08 | ||||||
| Gross profit | -0.59 | -0.57 | -0.55 | 1.06 | -2.29 | -0.53 | -0.53 | 1.72 | -0.45 | -0.44 | -0.24 | -0.09 | -0.17 | -0.15 | -0.13 | -0.08 | -0.06 | -0.05 | -0.08 | ||||||
| Total operating expenses | 53.53 | 55.98 | 46.86 | 42.61 | 45.96 | 45.54 | 40.43 | 38.11 | 34.75 | 33.86 | 29.45 | 25.34 | 25.70 | 22.08 | 18.26 | 16.49 | 14.83 | 12.82 | 13.08 | 10.46 | 6.86 | 6.34 | 3.64 | 3.96 | 3.25 |
| Operating income | -54.12 | -55.98 | -46.86 | -42.61 | -45.96 | -45.54 | -40.43 | -38.11 | -34.75 | -33.86 | -29.45 | -25.34 | -25.70 | -22.08 | -18.26 | -16.49 | -14.83 | -12.82 | -13.08 | -10.46 | -6.86 | -6.34 | -3.64 | -3.96 | -3.25 |
| Non-operating income (net) | 5.10 | 5.76 | 6.19 | 6.50 | 5.16 | 5.88 | 6.30 | 6.61 | 6.23 | 3.72 | 3.74 | 3.87 | 2.87 | 2.66 | 0.76 | 0.42 | 0.17 | 0.13 | 0.13 | 0.11 | 0.04 | 0.00 | 0.00 | 0.00 | 0.06 |
| Income before tax | -49.01 | -50.22 | -40.67 | -36.12 | -40.80 | -39.66 | -34.13 | -31.50 | -28.53 | -30.14 | -25.71 | -21.47 | -22.84 | -19.42 | -17.50 | -16.07 | -14.66 | -12.70 | -12.95 | -10.35 | -6.82 | -6.34 | -3.64 | -3.95 | -3.19 |
| Income tax expense | -0.48 | 0.48 | 3.60 | -0.50 | 0.34 | -3.11 | -2.66 | -0.76 | -0.42 | -0.17 | 42.81 | ||||||||||||||
| Net income | -49.01 | -50.22 | -40.67 | -36.12 | -40.80 | -39.66 | -34.13 | -31.50 | -28.53 | -30.14 | -25.71 | -21.47 | -22.84 | -19.42 | -17.50 | -16.07 | -14.66 | -12.70 | -12.95 | -10.35 | -6.82 | -6.34 | -3.64 | -3.95 | -3.19 |